Efficacy and safety of once-weekly semaglutide 2.0 mg versus 1.0 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B trial
Driven by breakthrough treatments for Type 2 Diabetes, Obesity, and Metabolic Disorders, GLP-1 therapies are reshaping healthcare, patient outcomes, and pharmaceutical revenues worldwide
A 28-day supply of the injectable or a 30-day supply of the pill equals one month of treatment
Have smaller portions, but packed with nutrition, think of your meals as mini but mighty, says Berjis
Arnicolide D inhibits oxidative stress-induced breast cancer cell growth and invasion through apoptosis, in Ferroptosis, and Parthanatos
P.AniniY.DruckerD